Micro-X Future Growth

Future criteria checks 2/6

Micro-X is forecast to grow earnings and revenue by 63.6% and 42.7% per annum respectively. EPS is expected to grow by 67.5% per annum. Return on equity is forecast to be -21.1% in 3 years.

Key information

63.6%

Earnings growth rate

67.5%

EPS growth rate

Medical Equipment earnings growth	16.8%
Revenue growth rate	42.7%
Future return on equity	-21.1%
Analyst coverage	Low
Last updated	28 Feb 2024

Recent future growth updates

Recent updates

Shareholders May Not Be So Generous With Micro-X Limited's (ASX:MX1) CEO Compensation And Here's Why

Nov 07

We Think Micro-X (ASX:MX1) Needs To Drive Business Growth Carefully

Jul 07

Here's Why We're Watching Micro-X's (ASX:MX1) Cash Burn Situation

Mar 01

What We Learned About Micro-X's (ASX:MX1) CEO Pay

Jan 29

What Kind Of Shareholders Hold The Majority In Micro-X Limited's (ASX:MX1) Shares?

Jan 08

Have Insiders Been Buying Micro-X Limited (ASX:MX1) Shares?

Dec 18

Micro-X Limited's (ASX:MX1) Shift From Loss To Profit

Nov 27

Earnings and Revenue Growth Forecasts

ASX:MX1 - Analysts future estimates and past financials data (AUD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
6/30/2026	49	-2	N/A	-3	1
6/30/2025	38	-4	N/A	-6	1
6/30/2024	23	-10	N/A	-2	1
12/31/2023	15	-15	-5	-5	N/A
9/30/2023	15	-13	-9	-8	N/A
6/30/2023	15	-11	-12	-11	N/A
3/31/2023	15	-11	-14	-13	N/A
12/31/2022	15	-12	-15	-14	N/A
9/30/2022	12	-15	-17	-16	N/A
6/30/2022	9	-17	-19	-18	N/A
3/31/2022	6	-18	-18	-16	N/A
12/31/2021	4	-19	-16	-15	N/A
9/30/2021	4	-17	-13	-12	N/A
6/30/2021	4	-15	-11	-10	N/A
3/31/2021	5	-13	-12	-11	N/A
12/31/2020	6	-11	-13	-12	N/A
9/30/2020	5	-10	-12	-11	N/A
6/30/2020	4	-10	-12	-9	N/A
3/31/2020	3	-9	-11	-8	N/A
12/31/2019	2	-8	-10	-7	N/A
9/30/2019	2	-9	-9	-7	N/A
6/30/2019	2	-10	-9	-7	N/A
3/31/2019	2	-14	-9	-8	N/A
12/31/2018	2	-18	-10	-9	N/A
9/30/2018	2	-17	-9	-8	N/A
6/30/2018	2	-17	-8	-8	N/A
3/31/2018	1	-14	-10	-9	N/A
12/31/2017	1	-11	-11	-11	N/A
9/30/2017	1	-12	N/A	-11	N/A
6/30/2017	1	-13	N/A	-11	N/A
3/31/2017	1	-13	N/A	-10	N/A
12/31/2016	1	-13	N/A	-9	N/A
9/30/2016	1	-12	N/A	-11	N/A
6/30/2016	1	-11	N/A	-13	N/A
3/31/2016	1	-12	N/A	-10	N/A
12/31/2015	0	-13	N/A	-8	N/A
9/30/2015	0	-11	N/A	-7	N/A
6/30/2015	0	-10	N/A	-6	N/A
6/30/2014	N/A	0	N/A	0	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: MX1 is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: MX1 is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: MX1 is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: MX1's revenue (42.7% per year) is forecast to grow faster than the Australian market (4.6% per year).

High Growth Revenue: MX1's revenue (42.7% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: MX1 is forecast to be unprofitable in 3 years.

Discover growth companies

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Micro-X Future Growth

Future criteria checks 2/6

Key information

Recent future growth updates

Consensus revenue estimates fall by 20%

Price target decreased by 11% to AU$0.25

Forecast breakeven date pushed back to 2025

Consensus forecasts updated

Price target decreased to AU$0.36

Price target decreased to AU$0.51

Recent updates

Micro-X Limited has filed a Follow-on Equity Offering in the amount of AUD 1 million.

Micro-X Limited has filed a Follow-on Equity Offering in the amount of AUD 4 million.

Micro-X Limited has filed a Follow-on Equity Offering in the amount of AUD 1 million.

New minor risk - Share price stability

Micro-X Limited (ASX:MX1) Doing What It Can To Lift Shares

Micro-X Reveals First Look At New Mobile Stroke Diagnosis Device

Consensus revenue estimates fall by 20%

Price target decreased by 11% to AU$0.25

New minor risk - Profitability

Micro-X Limited, Annual General Meeting, Nov 16, 2023

Full year 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

New minor risk - Financial data availability

Non-Executive Director exercised options to buy AU$174k worth of stock.

Sentiment Still Eluding Micro-X Limited (ASX:MX1)

Forecast breakeven date pushed back to 2025

Is Micro-X (ASX:MX1) In A Good Position To Invest In Growth?

First half 2023 earnings released: AU$0.008 loss per share (vs AU$0.019 loss in 1H 2022)

Less than half of directors are independent

Micro-X Limited announced that it has received AUD 7.454223 million in funding from Varex Imaging Corporation

Less than half of directors are independent

Shareholders May Not Be So Generous With Micro-X Limited's (ASX:MX1) CEO Compensation And Here's Why

Consensus forecasts updated

Less than half of directors are independent

Micro-X Limited, Annual General Meeting, Nov 14, 2022

Micro-X Limited Announces Resignation of Yasmin King as Director

Micro-X Limited announced that it expects to receive AUD 7.454223 million in funding from Varex Imaging Corporation

Micro-X Limited Launches Next Generation Micro-X Rover, the Rover Plus

Full year 2022 earnings: EPS and revenues miss analyst expectations

Price target decreased to AU$0.36

We Think Micro-X (ASX:MX1) Needs To Drive Business Growth Carefully

Price target decreased to AU$0.51

Micro-X Ltd Appoints Ilona Meyer to Its Board as A Non-Executive Director and Member of the Micro-X Audit & Risk Committee, Effective 7Th March 2022

Here's Why We're Watching Micro-X's (ASX:MX1) Cash Burn Situation

Consensus forecasts updated

Consensus revenue estimates fall by 34%

Full year 2021 earnings released: AU$0.037 loss per share (vs AU$0.043 loss in FY 2020)

Consensus revenue estimates fall to AU$4.20m

Micro-X Ltd Launches New Version of the Rover Mobile DR for Use in Small-Animal Veterinary Hospitals

Micro-X Limited Announces Rover FDA Approval Opens US Healthcare Market

Consensus forecasts updated

Analysts update estimates

First half 2021 earnings released: AU$0.013 loss per share (vs AU$0.025 loss in 1H 2020)

New 90-day high: AU$0.40

Micro-X Limited announced that it expects to receive AUD 30.5 million in funding

What We Learned About Micro-X's (ASX:MX1) CEO Pay

What Kind Of Shareholders Hold The Majority In Micro-X Limited's (ASX:MX1) Shares?

New 90-day high: AU$0.39

Micro-X Limited Signs $1.3 Million Rover Contract for Australian Defence Force

Have Insiders Been Buying Micro-X Limited (ASX:MX1) Shares?

Micro-X Limited Announces Rejoining of Jim McDowell as Non-Executive Director from January 1, 2021

New 90-day high: AU$0.36

Micro-X Limited's (ASX:MX1) Shift From Loss To Profit

Price target raised to AU$0.50

Micro-X Limited Amends Nano Distribution Agreement with Carestream Health Inc

Micro-X Ltd Announces Management Changes

New 90-day high: AU$0.26

Analysts update estimates

Micro-X Limited Signs $1.4 Million Contract for Rover Launches Micro-X Second Product

New 90-day high: AU$0.21

Micro-X Limited Auditor Raises 'Going Concern' Doubt

Full year earnings released - AU$0.043 loss per share

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings per Share Growth Forecasts

Future Return on Equity

Discover growth companies